Hoth Therapeutics Inc (NASDAQ:HOTH) has a beta value of 0.91 and has seen 5.07 million shares traded in the last trading session. The company, currently valued at $9.39M, closed the last trade at $1.36 per share which meant it lost -$0.11 on the day or -7.48% during that session. The HOTH stock price is -179.41% off its 52-week high price of $3.80 and 57.35% above the 52-week low of $0.58. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.93 million shares traded. The 3-month trading volume is 9.20 million shares.
The consensus among analysts is that Hoth Therapeutics Inc (HOTH) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.26.
Hoth Therapeutics Inc (NASDAQ:HOTH) trade information
Sporting -7.48% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the HOTH stock price touched $1.36 or saw a rise of 20.47%. Year-to-date, Hoth Therapeutics Inc shares have moved 81.79%, while the 5-day performance has seen it change -13.92%. Over the past 30 days, the shares of Hoth Therapeutics Inc (NASDAQ:HOTH) have changed 67.90%. Short interest in the company has seen 0.63 million shares shorted with days to cover at 1.16.
Hoth Therapeutics Inc (HOTH) estimates and forecasts
Figures show that Hoth Therapeutics Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 27.10% over the past 6 months, with this year growth rate of 40.87%, compared to 16.40% for the industry. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 15.18% over the past 5 years.
HOTH Dividends
Hoth Therapeutics Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Hoth Therapeutics Inc (NASDAQ:HOTH)’s Major holders
Insiders own 0.92% of the company shares, while shares held by institutions stand at 5.53% with a share float percentage of 5.58%. Investors are also buoyed by the number of investors in a company, with Hoth Therapeutics Inc having a total of 14.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund . As of Sep 30, 2024 , the former fund manager holds about 0.56% shares in the company for having 38.8 shares of worth $52773.0 while later fund manager owns 35.83 shares of worth $48734.0 as of Nov 30, 2024 , which makes it owner of about 0.52% of company’s outstanding stock.
